Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: a Multicenter, Open-label, Single-arm Phase 2 Study

Overview of attention for article published in Clinical Cancer Research, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 9 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 10 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Fighting Melanoma, 25 Oct 2022

Atezolizumab in combination with bevacizumab showed promising efficacy and manageable safety in patients with advanced mucosal…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.